ALLNUTRITION BCAA 2:1:1 1000 Xtra Caps delivers branched-chain amino acids in capsule form, with each serving providing L-leucine, L-isoleucine, and L-valine in the classic 2:1:1 ratio. The 180-capsule pack contains 6,000 mg of BCAAs per six-capsule serving, split as 3,000 mg L-leucine, 1,500 mg L-isoleucine, and 1,500 mg L-valine.
BCAAs are among the most widely used ingredients in sports nutrition, particularly by those engaged in regular resistance training, high-volume endurance sessions, or calorie-controlled eating phases. The capsule format means no mixing or measuring — simply take them as part of your training day routine.
Manufactured by ALLNUTRITION, this product is suited to athletes and active individuals looking to keep their amino acid intake consistent alongside a structured training programme and balanced diet.
| Weight | 0.2750 kg |
|---|---|
| Ingredients | BCAA (L-leucine, L-vanilline, L-Isoleucine), BCAA (L-leucine, L-valine, L-isoleucine), gelatin capsule coating. |
| Recommended Use | From 1 to 2 servings daily. On workout days: one serving before workout and one portion after the workout. On rest days: one serving in the morning on an empty stomach. One serving is 6 capsules. |
| Warnings | This product is intended for physically active people over 18 years of age. Do not consume if you are allergic to any of the ingredients. Do not exceed the recommended daily dose. Food supplement cannot be used as a substitute for a diversified diet. A balanced diet and a healthy lifestyle are recommended. Always close the packaging after use. Store in a dry and cool place, out of reach of young children, at the temperature 15-25°C. |
| Brand | Allnutrition |
| Nutritional Information | Recommended daily dose (6 caps) • BCAA 6000 mg • (L-leucine: 3000 mg, L-vanilline: 1500 mg, L-Isoleucine: 1500 mg) |
Be the first to review “BCAA 2:1:1 1000 Xtra Caps – 180 caps”
Related products
Health Stuff
Health Stuff
Antioxidants
Health Stuff
Health Stuff
Health Stuff
Health Stuff
Health Stuff
Reviews
There are no reviews yet.